HSPG2 (perlecan) is cleaved by BMP1, TLL1, TLL2, Cathepsin L1

Stable Identifier
R-HSA-3814820
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Endorepellin is the 85-kDa C-terminal domain V of HSPG2 (perlecan). It consists of a series of laminin-like globular (LG) domains interconnected by short epidermal growth factor-like repeats (Hohenester & Engel 2002). Endorepellin has angiostatic activity (Mongiat et al. 2003) which is primarily localised in the LG3 domain (Bix et al. 2004). Bone morphogenetic protein 1 (BMP1), its isoform mammalian Tolloid (mTLD), mammalian Tolloid-like-1 and -2 (TLL1, TLL2) (Gonzalez et al. 2005) and cathepsin-L1 (Cailhier et al. 2008) can liberate LG3 by cleaving endorepellin between Asn4196 and Asp4197.

Literature References
PubMed ID Title Journal Year
15591058 BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan

Gonzalez, EM, Reed, CC, Bix, G, Fu, J, Zhang, Y, Gopalakrishnan, B, Greenspan, DS, Iozzo, RV

J. Biol. Chem. 2005
18658137 Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis

Cailhier, JF, Sirois, I, Laplante, P, Lepage, S, Raymond, MA, Brassard, N, Prat, A, Iozzo, RV, Pshezhetsky, AV, H├ębert, MJ

J. Biol. Chem. 2008
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
serine-type endopeptidase activity of BMP1, TLL1, TLL2, Cathepsin L1 [extracellular region]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created
Cite Us!